Dexmedetomidine-ketamine and Dexmedetomidine-Midazolam-Fentanyl combinations for sedation in chemoport insertion procedure
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0000951
- Lead Sponsor
- Ewha Womans University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
1) 18-65 age
2) ASA (American society of anesthesiologists)class I-II
3) Patients undergoing chemoport insertion procedure in the Ewha womans university mokdong hospital
Exclusion Criteria
1) Contraindication to dexmedetomidine, Ketamine, Midazolam, Fentanyl
2) underlying psychologic disorder
3) > ASA class 3
4) decreased renal, hepatic function
5) respiratory disease, sleep apnea, airway obstructive disease.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recovery time : time to spontaneous eye opening, length of stay in RR, time for achieving Aldrete score : 9
- Secondary Outcome Measures
Name Time Method satisfactory score of surgeon, anesthesiologist and patient;Respiratory variables : SpO2, EtCO2(nasal), apnea, dyspnea, airway spasm ;sedation score, analgesic status;Hemodynamic variables : BP(s/d/m), HR